Dark

Check out our API

AZTA
Azenta, Inc.
stock NASDAQ

At Close

Jul 31, 2026 3:59:53 PM EDT

28.14USD-2.393%(-0.69)456,575

24.33Bid 32.18Ask 7.85Spread

Pre-market

Jul 30, 2026 9:28:30 AM EDT

28.60USD+1.132%(+0.32)0

After-hours

Jul 31, 2026 4:00:30 PM EDT

28.13USD-0.036%(-0.01)70,877

OverviewOptionsHistoricalExchangesShortsNews

Jan 24, 2022

08:01AM EST Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference PR Newswire

Jan 6, 2022

04:09PM EST Azenta Names Matthew McManus COO Benzinga

04:05PM EST Azenta Life Sciences Names Matthew McManus Chief Operating Officer PR Newswire

09:00AM EST PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBios HiFi sequencing platforms across Azentas newly combined company and support Azentas mission to enable life science companies to deliver impactful breakthroughs and therapies to market faster. GlobeNewswire Inc

Dec 21, 2021

04:15PM EST Azenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference PR Newswire

Dec 20, 2021

04:15PM EST Azenta Life Sciences to Participate in the 24th Annual Needham Virtual Growth PR Newswire

Dec 1, 2021

08:22AM EST Brooks Automation Reports Completion Of Corporate Name Change To 'Azenta,' Ticker Change To 'AZTA' Benzinga

Share